
    
      This study is an open-label, randomized, single dose, four period, balanced crossover study
      to assess in eligible healthy male or female subjects:

        -  The relative bioavailability of the wet milled GSK1322322 tablet formulation with and
           without food compared to an oral mesylate salt solution.

        -  The effect of body weight on the pharmacokinetics of GSK1322322 when given either orally
           or IV.

        -  The absolute bioavailability of the wet milled tablet and the oral mesylate salt
           solution compared to the IV formulation.
    
  